the aid library

LIST OPTIONS

Filter

6483

UNHAS COVID19 Standard Operating Procedures (SOP)

Reliefweb; OCHA Services; United Nations Humanitarian Air Service (UNHAS); Republic of South Sudan; et al. (2020) CC

Covid19 - Standard Operating Procedures – UNHAS ROSS This SOP defines WFP Aviation/UNHAS procedures to be followed when operating in areas affected by the current outbreak of the coronavirus disease (COVID-19). This SOP will be communicated to UNHAS staff, Operators, and user organisations. Acco... more

External Link

Whole of Syria Joint Statement: Protecting Maternal, Infant and Young Child Nutrition during the Earthquake response in Syria (12th of February 2023)

Nutrition Cluster; Save the Children; United Nation Children's Fund; World Health Organization (2023) CC

UNICEF, WHO Whole of Syria Nutrition, Cluster, the Global Nutrition Cluster, the IFE Core Group, and partners call for ALL involved in the response to the earthquakes in Syria to protect, promote, and support the feeding and care of infants and young children, their caregivers, especially pregnant, ... more

External Link

Climate Solutions Double as Health Interventions

Mailloux, N.A. et al. (2021) CC

Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339 The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and... more

External Link

Working Together to Fight Antimicrobial Resistance

Pan American Health Organisation PAHO; FAO and OIE (2022) C_WHO

Antimicrobial resistance (AMR) represents a major global threat across human, animal, plant food and environmental sectors, threatening the effective treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi, resulting in prolonged illness and increased mor... more

Download (248)

View PDF (198)

Nigeria: reducing the indirect causes of maternal morbidity and mortality: the RICOM3 Project

World Health Organisation (WHO) (2023) C_WHO

Nigeria reported its first case of COVID-19 at the end of February 2020 and subsequently experienced four waves, with peaks in June 2020 and January, August and December 2021. The COVID-19 pandemic severely impacted the economy of Nigeria and caused disruption of health services nationwide. During... more

Download (193)

View PDF (224)

Third progress analysis of implementation of antimicrobial resistance national action plans in the WHO South-East Asia Region

World Health Organization WHO (2022) C_WHO

Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder or impossible to treat, and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has... more

External Link

Qualité de L'Apport des Relais dans la PCIME Communautaire au Bénin; Quality of the contribution of community volunteers in Benin community-based IMCI

Panaveyi Vicky Malou Adom, Edgard Marius Ouendo, Lamidhi Salami, Gado Napo- Koura, Michel Makoutodé Cairn Info (2014) C2

Introduction : de nos jours, face à la pénurie grandissante de personnel de santé qualifié et face au défi de l’atteinte des Objectifs du Millénaire pour le Développement, la participation communautaire est devenue une réalité incontournable. Dans la zone sanitaire Avrankou Adjarra Ak... more

External Link

Major Infectious Diseases. Disease Control Priorities, Third Edition : Volume 6

Holmes, King K.; Bertozzi, Stefano; Bloom, Barry R.; Jha, Prabhat World Bank (2017) CC

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective pack... more

Download (154)

View PDF (204)

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021
recommended

World Health Organization WHO (2021) C_WHO

WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma... more

External Link

Antimicrobial resistance learning channel
recommended

World Health Organization WHO (2022) CC

Antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. AMR threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. It occurs when microorganisms develop resistance to me... more

Download (215)

View PDF (294)

Improving Maternal Mental Health
recommended

World Health Organization WHO (2008) C_WHO

The mental health of women not only adversely affects them, but its impact on their developing infant is also severe. If the ability of women to take care of their baby is compromised, the survival and development of the infant is jeopardized. Maternal depression in resource-constrained settings ... more

External Link

Effects of Heat

National Institute of Environmental Health Sciences (2022) CC

Over long periods of time, individuals and communities can adapt to their local climates. When both warmer and colder temperatures go above or below those norms rapidly, scientific evidence shows that people become vulnerable to associated health effects related to those extremes. Studies suggest th... more

Download (330)

View PDF (439)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (194)

View PDF (270)

Клиническое определение случая состояния после COVID-19 методом дельфийского консенсуса, 6 октября 2021 г.
recommended

World Health Organization WHO (2021) C_WHO

Download (221)

View PDF (304)

Adjusting business models to sustain agri-food enterprises during COVID-19

Food and Agriculture Organization of the United Nations (FAO) (2020) CC

Unlike foot and mouth disease, the avian flu, e-coli or listeria, the COVID-19 pandemic has not spread directly through livestock or agriculture commodities, and has therefore not directly disrupted on-farm production. However, the crisis is undermining the ability of farms and agri-enterprises to e... more

Download (126)

View PDF (177)

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (Arabic Version)
recommended

World Health Organization WHO (2021) C_WHO

Download (214)

View PDF (229)

Revised COVID-19 Testing Strategy
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi... more

Download (191)

View PDF (225)

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

Download (108)

View PDF (102)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Download (246)

View PDF (963)

How can financial risk protection be expanded in Myanmar?

Phone Myint; Than Tun Sein; Cassels, Andrew World Health Organization (WHO) (2015) C_WHO

Policy Note #4: Myanmar Health Systems in Transition Policy Notes Series
Protecting people from financial hardship when they fall ill is one of the two key elements of universal health coverage (UHC). In practice, this means that the majority of health care costs have to be met from government ... more

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 recommended

Antimicrobial resistance learning channel recommended

Improving Maternal Mental Health recommended

Клиническое определение случая состояния после COVID-19 методом дельфийского консенсуса, 6 октября 2021 г. recommended

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (Arabic Version) recommended

Revised COVID-19 Testing Strategy recommended

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021
recommended

Antimicrobial resistance learning channel
recommended

Improving Maternal Mental Health
recommended

Клиническое определение случая состояния после COVID-19 методом дельфийского консенсуса, 6 октября 2021 г.
recommended

A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (Arabic Version)
recommended

Revised COVID-19 Testing Strategy
recommended